Building on this foundation, our work identifies the rs72856331 SNP within the USP47 promoter that modulates GLI3 binding, enhances USP47 expression, and drives EMT through Snai1 stabilization, thereby contributing to GC progression. Here, GLI3 is linked to gastric cancer.